Drugs / budesonide/formoterol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT05111262 Comparator | Dec 2021 → Sep 2025 overdue | asthma | Washington University School of Medicine | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | budesonide/formoterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05111262 ↗ |
| Route | Inhaled | “symptom-driven ICS-containing inhalers” NCT05111262 ↗ |